PROC

Procaps Group, S.A. Ordinary Shares
PROC

Delisted

PROC was delisted on the 3rd of February, 2025.

Back to rankings
 

About: Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Employees: 5,500

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™